Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial.
about
Prostanoids for intermittent claudicationAntiplatelet agents for intermittent claudicationProstanoids for intermittent claudicationRecent advance in antiplatelet therapy: the mechanisms, evidence and approach to the problemsPeripheral arterial disease.Long-term survival after initial hospital admission for peripheral arterial disease in the lower extremitiesMedical management of intermittent claudication.Peripheral arterial disease of the lower extremities.Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies.Effects of Beraprost sodium on subjective symptoms in diabetic patients with peripheral arterial disease.The evaluation of cardiac and peripheral arterial disease in patients with diabetes mellitus.Peripheral arterial disease in the elderly.Peripheral artery disease: therapeutic advances.Effect of beraprost sodium on arterial stiffness in patients with type 2 diabetic nephropathy.Thromboangiitis Obliterans (Buerger's Disease)-Current Practices.Pharmacologic therapy for intermittent claudication.Treatment strategies for peripheral artery disease.Medical management for chronic atherosclerotic peripheral arterial disease.Intermittent claudication: new targets for drug development.A randomized trial of iloprost in patients with intermittent claudication.Randomized pilot trial between prostaglandin I2 analog and anti-platelet drugs on peripheral arterial disease in hemodialysis patients.Effects of oral beraprost sodium, a prostaglandin I2 analogue, on endothelium dependent vasodilatation in the forearm of patients with coronary artery disease.
P2860
Q24197689-9B669ED4-E1A5-46F4-B082-783ED197EDA0Q24235178-BB6E07CE-9D30-4826-AC8B-F1C9CDB9A4BBQ24247757-55C234FD-3B25-41AB-AD6D-8C2057A09713Q28218351-20FCE772-9154-42FF-BD20-C3672445C2D5Q30863696-B6E44F78-93F9-4DF6-AE15-08FF2718497EQ33498124-9063E120-9EEE-4F8A-B0C9-E5278B0C0AADQ35920953-DBF048EF-E69E-4244-AB04-134E7AB09AE5Q35990502-B30328F4-6994-4A73-9E4C-E99DB5A9BF2CQ36731233-2BA031D4-9FA1-4EDF-8534-2A1A3DDEEC47Q36877857-EB543471-2A1A-49CB-AB60-D5D04A829AE8Q37037463-231D24D5-91F2-42AB-B54D-3BA60D8DC149Q37069056-4035F405-8B6E-491C-AEBE-B6D12E80C6F9Q37134500-E050077B-032B-4028-BC86-87B12E374221Q37153492-E1C07A0C-C7F5-4AC1-AA51-B861C945B6F7Q37206152-A2ACD7E4-A332-410B-8598-B0A6D8703B67Q37461418-EE01A20F-1545-43CA-BDE0-43F9377DC953Q37519704-8D2147AE-9E7D-4DCC-8306-2BCACA9B0A55Q38050495-4B89760E-6139-4A40-9A4D-D2D9307BC7FCQ38115205-011B74CD-E8A0-4A37-B85B-275E9832AFEDQ46677272-2EECE184-4C1C-47DB-A523-6711DA66735DQ48086607-AB073312-D870-4D73-9813-7E6798AA929BQ53627165-FD56B41E-0CD6-479B-AE70-BD8AF43FE2D1
P2860
Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Treatment of intermittent clau ...... randomized, controlled trial.
@en
Treatment of intermittent clau ...... randomized, controlled trial.
@nl
type
label
Treatment of intermittent clau ...... randomized, controlled trial.
@en
Treatment of intermittent clau ...... randomized, controlled trial.
@nl
prefLabel
Treatment of intermittent clau ...... randomized, controlled trial.
@en
Treatment of intermittent clau ...... randomized, controlled trial.
@nl
P2093
P1476
Treatment of intermittent clau ...... randomized, controlled trial.
@en
P2093
Alan T Hirsch
Emile R Mohler
Jeffrey W Olin
Michael Wade
Roger Jeffs
William R Hiatt
P304
P356
10.1016/S0735-1097(03)00299-7
P407
P577
2003-05-01T00:00:00Z